The median percentage of CD68 was 20.44% (IQR 7.26%–37.20%) in CE and 14.32% (IQR 9.90%–31.39%) in LAA, while CD163 was 10.33% (IQR 5.52%–21.91%) in CE and 8.95% (IQR 4.20%–36.28%) in LAA. The gene discussed is CD163; the disease is cholesteryl ester measurement.